Inhibition of bile acid (BA)-converting Clostridium species that are responsible for converting primary BAs to secondary BAs can increase the expression of CXCL16 on LSECs to attract the infiltration of hepatic CXCR6+ NKT cells to inhibit liver cancer progression. The gene discussed is CXCL16; the disease is liver cancer.